Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

Tabla de Políticas Médicas

ID Título Revisión Descripción Acceso
11.003.072 Genetic Testing For Marfan Syndrome, Thoracic Aortic Aneurysms And Dissections, And Related Disorders Mar 2026 Marfan syndrome (mfs) is a systemic connective tissue disease (ctd) with a high degree of clinical... Ver
11.003.073 Laboratory And Genetic Testing For Use Of 5-Fluorouracil In Patients With Cancer Apr 2025 Variability in systemic exposure to 5-fluorouracil chemotherapy is thought to directly impact 5-fluorouracil... Ver
11.003.075 Proteomic Testing For Targeted Therapy In Non-Small-Cell Lung Cancer Dec 2025 Proteomic testing has been proposed as a way to predict survival outcomes, as well as the response to and... Ver
11.003.076 Multibiomarker Disease Activity Blood Test For Rheumatoid Arthritis Jul 2026 Assessment of disease activity in rheumatoid arthritis (ra) is an important component of management with a... Ver
11.003.077 Los ensayos de varios analitos con el análisis algorítmico para predecir el ries Oct 2016 ... Ver
11.003.078 Noninvasive Prenatal Screening For Fetal Aneuploidies And Microdeletions Using Cell-Free Fetal Dna Jun 2026 National guidelines recommend that all pregnant individuals be offered screening for fetal chromosomal... Ver
11.003.079 Invasive Prenatal (Fetal) Diagnostic Testing Sep 2025 Invasive prenatal (fetal) diagnostic testing may be used to identify pathogenic genetic alterations in... Ver
11.003.081 Genetic Testing For Macular Degeneration Apr 2026 Age-related macular degeneration is a complex disease involving both genetic and environmental influences.... Ver
11.003.082 Genetic Testing For Facioscapulohumeral Muscular Dystrophy Mar 2026 Facioscapulohumeral muscular dystrophy (fshd) is an autosomal dominant disease that typically presents before... Ver
11.003.083 Genetic Testing For Charge Syndrome Mar 2026 Charge syndrome is a rare genetic condition associated with multiple congenital anomalies. in many... Ver
11.003.084 Genetic Testing For Idiopathic Dilated Cardiomyopathy Mar 2026 Dilated cardiomyopathy (dcm) is characterized by progressive left ventricular enlargement and systolic... Ver
11.003.085 Genetic Testing For Limb-Girdle Muscular Dystrophies Jun 2024 ... Ver
11.003.086 Kif6 Genotyping For Predicting Cardiovascular Risk Aug 2021 Genetic testing to determine kinesin-like protein 6 (kif6) trp719arg variant status is being evaluated as a... Ver
11.003.087 Molecular Testing In The Management Of Pulmonary Nodules Jun 2026 Plasma-based proteomic screening and gene expression profiling of bronchial brushing are molecular tests... Ver
11.003.088 Molecular Testing For Chronic Heart Failure And Heart Transplant Jun 2021 Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... Ver
11.003.089 Circulating Tumor Dna And Circulating Tumor Cells For Cancer Management (Liquid Biopsy) Jul 2026 Circulating tumor dna (ctdna) and circulating tumor cells (ctcs) in peripheral blood, referred to as... Ver
11.003.090 Gene Expression Profiling For Uveal Melanoma Mar 2025 Uveal melanoma is associated with a high rate of metastatic disease, and survival after the development of... Ver
11.003.092 Proteogenomic Testing For Patients With Cancer Jul 2026 Proteogenomics refers to the integration of genomic information with proteomic and transcriptomic information... Ver
11.003.093 Genetic Testing For Mitochondrial Disorders Oct 2025 Mitochondrial diseases are multisystem diseases that arise from dysfunction in the mitochondrial protein... Ver
11.003.094 Serum Biomarket Panel Testing For Systemic Lupus Erythematosus And Other Connective Tissue Deseases Jul 2026 Systemic lupus erythematosus (sle) is an autoimmune connective tissue disease (ctd) that can be difficult to... Ver